
Exploiting Synthetic Lethality and Network Biology to Overcome EGFR Inhibitor Resistance in Lung Cancer
Keywords: SCLC; small cell lung cancer; NSCLC; non-small cell lung cancer; EGFR; epidermal growth factor receptor; EGFRi; EGFR inhibitor; PFS; progression-free survival; ORR; objective response rate; HER2; human epidermal growth factor receptor 2; EMT; epithelialâ